글로벌 임신성 빈혈 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 임신성 빈혈 시장

임신성 빈혈 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 상기 연구 예측 기간 동안 4.80%의 CAGR로 성장하고 있다고 분석합니다. 임신 중 혈액 희석 사례 증가 및 COVID-19 기간 중 임산부 인구 증가 등이 있습니다.

새로운 치료 옵션에 대한 높은 수요와 다양한 제품 출시도 시장 성장을 촉진합니다. 게다가 시장 참여자 간의 파트너십과 협력 증가와 더 나은 여성 건강에 대한 정부의 호의적인 지원은 시장 성장의 기회로 작용합니다. 그러나 대체 허브 제품의 존재와 엄격한 규제 지침은 글로벌 임신 빈혈 시장을 방해할 수 있습니다.

임신성 빈혈은 여성에게 적혈구가 너무 적어서 고통받는 여성에게 산소가 부족해지는 특징이 있습니다. 이러한 산소 부족은 신경과 근육 조직의 활동에 영향을 미치고 궁극적으로 신체 전체 과정에 영향을 미칩니다. 게다가 임신 중에 태아가 발달하려면 효율적인 혈액이 필요하므로 적절한 식단과 보충제가 제공되지 않으면 산모가 빈혈이 됩니다. 엄격한 채식주의 여성 인구는 임신성 빈혈 위험이 더 높기 때문에 신체 요구 사항을 충족하기 위해 다른 보충제에 크게 의존합니다. 임신성 빈혈의 일반적인 관련 증상에는 창백한 피부, 피로, 집중력 저하, 빠른 심장 박동, 호흡 곤란 등이 있습니다. 임신성 빈혈은 시트르산 제1철 암모늄, 황산 제1철, 덱스트란 철, 종합 비타민, 엽산 유도체 등을 섭취하여 치료할 수 있습니다.

WHO 보고서에 따르면 전 세계 임산부의 약 40%가 빈혈을 앓고 있으며, 이는 적혈구 수를 충족하기 위해 보충제와 약물에 의존하고 있어 시장이 수익성 있게 성장할 것으로 예상됩니다.

This pregnancy anemia market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Pregnancy Anemia Market Scope and Market Size

Pregnancy anemia market is segmented on the basis of type, treatment, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the pregnancy anemia market is segmented into iron-deficiency anemia, folate-deficiency anemia, vitamin B12 deficiency.
• On the basis of treatment, the pregnancy anemia market is segmented into folic acid supplements, iron supplement, others.
• On the basis of end-users, the Pregnancy anemia market is segmented into clinics, hospitals, homecare, others.
• On the basis of distribution channel, the Pregnancy anemia market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy, others. 

Pregnancy Anemia Market Country Level Analysis

Pregnancy anemia market is analysed and market size information is provided by country, type, treatment,  end-users and distribution channel as referenced above.

The countries covered in the Pregnancy anemia market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to rising trend of smoking among women population who are at higher risk of pregnancy anemia and increase in number of healthcare facilities providing quality healthcare services. Europe accounts the second largest market share second largest market share due to increasing awareness about reproductive health among the public and increasing collaboration and partnership for development of novel therapies.  Asia-Pacific is expected to account for the largest market share over coming years for the Pregnancy anemia market due to increasing research and developmental activities for development of novel therapies and increasing investment for development of advanced manufacturing facilities.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Pregnancy anemia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Pregnancy Anemia Market Share Analysis

Pregnancy anemia market competitive landscape provides details by competitor, details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Pregnancy anemia market.

임신성 빈혈 시장의 주요 기업으로는 Spirochem Lifesciences Pvt Ltd., Vifor Pharma Management Ltd., AMAG Pharmaceuticals, Fresenius SE & Co. KGaA, Akebia Therapeutics, CHO-A Pharmaceutical Co., Ltd., LUPIN, Orion Pharma Ltd, SHIELD THERAPEUTICS, Sanofi, Teva Pharmaceutical Industries Ltd., Advanz Pharmaceutical, GlaxoSmithKline plc., Alkem Labs., Hikma Pharmaceuticals PLC, Avion Pharmaceuticals LLC, Allergan, Gland Pharma Limited, PHARMACOSMOS A/S 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-60278